OCT 22, 2021 12:35 PM PDT

Cannabinoid Pain Treatment for Kidney Disease Patients

WRITTEN BY: Kerry Charron

According to a recent review of cannabis in kidney disease symptom management conducted by University of British Columbia researchers, cannabis treatment has the potential to manage symptoms of chronic kidney disease (CKD) and end stage renal disease (ESRD). The review highlighted the effectiveness of cannabis’s effectiveness in managing neuropathic pain that afflicts a majority of patients undergoing renal replacement therapy such as dialysis. The researchers found that using the lowest cannabis dosage possible was effective for pain management and offered a less addictive alternative to opioid pain management options.

Cannabinoid research has been hindered by historical stigma and illegal status, so there is minimal established research on cannabis’s adverse effects and benefits for patients with CKD. Mount Sinai Hospital Nephrologist Dr. Joshua Rein pointed out the importance of knowing the side effect profile of each route of administration in light of mixed evidence highlighting the benefits and potential adverse effects of cannabis. Some studies suggest that there may be an increased risk of heart attacks or stroke for some patients, while some studies may show an increased risk of lung infection. Overall, Dr. Rein recommends that CKD patients with pulmonary and respiratory diseases avoid smoking and instead seek out other options such as topical creams, tinctures, and edibles.

As cannabis treatments for those with CKD become more prevalent, this increased access will potentially reduce opioid dependence. Over 60% of dialysis patients have at least one opioid prescription despite mixed results regarding opioid’s effectiveness in pain reduction. Cannabis is reported to alleviate the pain, nausea and anxiety afflicting CKD patients.

Research on cannabinoids and renal function will continue to explore the roles that CB1 and CB2 receptors play in cannabinoid kidney treatments. Both receptors may be possible therapeutic targets managing renal deterioration due to diabetes. Future research will also explore the properties of different cannabinoids and most appropriate strains for CKD patients.

 

Sources: Canadian Journal of Kidney Health & Disease, Current Opinion in Nephrology and Hypertension

About the Author
BA and MA in English, MPS in Human Relations, and Ed.D. in Higher Education Administration
Kerry Charron writes about medical cannabis research. She has experience working in a Florida cultivation center and has participated in advocacy efforts for medical cannabis.
You May Also Like
JUL 01, 2022
Cannabis Sciences
Cannabis And Aging
JUL 01, 2022
Cannabis And Aging
How does cannabis affect our aging process? Does it accelerate it or slow it down?
OCT 13, 2022
Cannabis Sciences
High Doses of CBD Safe for Driving
OCT 13, 2022
High Doses of CBD Safe for Driving
The University of Sydney research team studied the effects of cannabidiol (CBD) on driving, and they found that the high ...
OCT 12, 2022
Cannabis Sciences
Cannabis Use for Menopausal Symptoms
OCT 12, 2022
Cannabis Use for Menopausal Symptoms
A study published in Menopause found that women are increasingly using medical cannabis to alleviate menopause-related s ...
OCT 18, 2022
Cannabis Sciences
Study Finds Hemp Byproducts Are a Safe Food Source for Lambs
OCT 18, 2022
Study Finds Hemp Byproducts Are a Safe Food Source for Lambs
An Oregon State University research team found that hemp byproducts are a safe food source for lambs. The study was rece ...
NOV 01, 2022
Cannabis Sciences
A Tale of Two THCs
NOV 01, 2022
A Tale of Two THCs
University of Connecticut researchers examined the differences between two closely related cannabinoids from the cannabi ...
NOV 03, 2022
Cannabis Sciences
Can CBD Help Dogs?
NOV 03, 2022
Can CBD Help Dogs?
The use of CBD infused foods and supplements is getting more popular in the canine community. But does CBD actually help ...
Loading Comments...